Mori T, Yamauchi Y, Shiozawa K
Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo.
Tuber Lung Dis. 1996 Jun;77(3):269-73. doi: 10.1016/s0962-8479(96)90012-x.
In the mass bacille Calmette-Guérin (BCG) vaccination programme using the multipuncture method practised in Japan for young children, lymph node swelling is a not uncommon complication and its management is sometimes unnecessarily radical.
To determine the frequency of lymphadenitis after BCG vaccination with the multipuncture method, and to describe its clinical features.
A total of 34,516 children aged 0-3 years, who received primary vaccination with BCG between 1985 and 1989, were observed for the occurrence of lymphadenopathy. Oral explanation was given to the parents about lymph node swelling, and a postcard with a reporting form was given, to be returned if any lymph node swelling was observed in the baby. The parents were then contacted, and invited to our clinic for further observation. Cases with one or more swollen nodes greater than 7 mm were included in this analysis as cases of lymphadenopathy.
The frequency of lymphadenopathy was 0.73% (95% CI 0.65-0.83). Babies under 1 year of age had higher incidence. Lymph nodes greater than 10 mm were seen among 0.40% of babies, with a higher rate among boys than in girls (0.95% and 0.50%, respectively). Sixty-five percent of the cases were first noticed 4-6 weeks after vaccination; others were detected before or after that period. Nineteen percent of the cases had multiple swollen nodes, and 2% had adenitis only outside the axilla. Eight cases progressed to suppurative adenitis with rupture, comprising 0.02% (95% CI 0.012%-0.046%) of those vaccinated. In the remaining cases the swelling subsided quickly (92% within 2 months and the others later), with no medical or surgical treatment.
在日本针对幼儿实施的采用多点刺种法的卡介苗大规模接种计划中,淋巴结肿大是一种并不罕见的并发症,其处理有时过于激进。
确定采用多点刺种法接种卡介苗后淋巴结炎的发生率,并描述其临床特征。
对1985年至1989年间接受卡介苗初次接种的34516名0至3岁儿童进行观察,以了解淋巴结病的发生情况。向家长进行了关于淋巴结肿大的口头解释,并发放了带有报告表的明信片,若婴儿出现任何淋巴结肿大情况需返还明信片。随后与家长取得联系,并邀请他们到我们的诊所进行进一步观察。将一个或多个肿大淋巴结直径大于7毫米的病例纳入本分析作为淋巴结病病例。
淋巴结病的发生率为0.73%(95%可信区间0.65 - 0.83)。1岁以下婴儿的发病率较高。0.40%的婴儿出现直径大于10毫米的淋巴结,男孩的发生率高于女孩(分别为0.95%和0.50%)。65%的病例在接种后4至6周首次被发现;其他病例在此期间之前或之后被检测到。19%的病例有多个肿大淋巴结,2%的病例仅在腋窝外出现腺炎。8例进展为化脓性腺炎并破溃,占接种者的0.02%(95%可信区间0.012% - 0.046%)。其余病例肿胀迅速消退(92%在2个月内消退,其他病例稍后消退),无需药物或手术治疗。